Skip to main content
. 2014 Feb 11;2(2):91–98. doi: 10.1177/2050640614523596

Figure 2.

Figure 2.

Estimation of the risk of developing oesophageal adenocarcinoma from Barrett’s oesophagus by prescription density of inhaled combined β-agonist and steroid in quintiles, corrected for age, gender, and smoking.

Values are hazard ratios and 95% confidence intervals. p = 0.005 for trend.